NCT00186420View on ClinicalTrials.gov

Adjuvant Taxotere in Patients With High Risk Prostate Cancer Post Prostatectomy and Radiation

PHASE2CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

January 31, 2006

Study Completion Date

September 30, 2009

Conditions
Prostate Cancer
Interventions
DRUG

Taxotere

Trial Locations (1)

94305

Stanford University Cancer Center, Stanford

Sponsors

Collaborators (1)

Aventis Pharmaceuticals
All Listed Sponsors
collaborator

Aventis Pharmaceuticals

INDUSTRY

lead

Stanford University

OTHER